These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25336515)

  • 1. Mechanisms of unexplained neurological deterioration after intravenous thrombolysis.
    Tisserand M; Seners P; Turc G; Legrand L; Labeyrie MA; Charron S; Méder JF; Mas JL; Oppenheim C; Baron JC
    Stroke; 2014 Dec; 45(12):3527-34. PubMed ID: 25336515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors.
    Seners P; Turc G; Tisserand M; Legrand L; Labeyrie MA; Calvet D; Meder JF; Mas JL; Oppenheim C; Baron JC
    Stroke; 2014 Jul; 45(7):2004-9. PubMed ID: 24876087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Associated With Thrombus Extension?
    Seners P; Hurford R; Tisserand M; Turc G; Legrand L; Naggara O; Mas JL; Oppenheim C; Baron JC
    Stroke; 2017 Feb; 48(2):348-352. PubMed ID: 28034965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
    Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
    Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of cerebral artery recanalization in patients with stroke with and without neurological improvement after intravenous thrombolysis.
    Kharitonova TV; Melo TP; Andersen G; Egido JA; Castillo J; Wahlgren N;
    Stroke; 2013 Sep; 44(9):2513-8. PubMed ID: 23881960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke.
    Savitz SI; Schlaug G; Caplan L; Selim M
    Stroke; 2005 Jul; 36(7):1447-51. PubMed ID: 15947268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How sustained is 24-hour diffusion-weighted imaging lesion reversal? Serial magnetic resonance imaging in a patient cohort thrombolyzed within 4.5 hours of stroke onset.
    Soize S; Tisserand M; Charron S; Turc G; Ben Hassen W; Labeyrie MA; Legrand L; Mas JL; Pierot L; Meder JF; Baron JC; Oppenheim C
    Stroke; 2015 Mar; 46(3):704-10. PubMed ID: 25649805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time.
    Aoki J; Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Watanabe M; Kobayashi K; Sakai K; Sakamoto Y
    Cerebrovasc Dis; 2011; 31(5):435-41. PubMed ID: 21346348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era.
    Chalela JA; Kang DW; Luby M; Ezzeddine M; Latour LL; Todd JW; Dunn B; Warach S
    Ann Neurol; 2004 Jan; 55(1):105-12. PubMed ID: 14705118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intravenous Thrombolysis on the Time Course of the Apparent Diffusion Coefficient in Acute Middle Cerebral Artery Infarction.
    Kretzer L; Gräßel D; Bokemeyer MA; Günther A; Witte OW; Axer H; Ringer TM
    J Neuroimaging; 2015; 25(6):978-82. PubMed ID: 25895155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of baseline magnetic resonance imaging (MRI) apparent diffusion coefficient lesion volume on functional outcome in ischemic stroke.
    Ma L; Gao PY; Hu QM; Lin Y; Jing LN; Xue J; Chen ZJ; Wang YJ; Liu ML; Cai YF
    Neurol Res; 2011 Jun; 33(5):494-502. PubMed ID: 21669118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.